REGENOCELL THERAPEUTICS, INC. Interest Expense
REGENOCELL THERAPEUTICS, INC. reported Interest Expense of $441.22 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2012-05-25.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2012-05-25
- REGENOCELL THERAPEUTICS, INC. interest expense for the quarter ending 2011-12-31 was $50.19K, a 30.61% decline year-over-year.
- REGENOCELL THERAPEUTICS, INC. interest expense for the quarter ending 2011-09-30 was $206.01K, a 2845.50% increase year-over-year.
- REGENOCELL THERAPEUTICS, INC. interest expense for the quarter ending 2011-06-30 was $94.36K, a 59.00% decline year-over-year.
- REGENOCELL THERAPEUTICS, INC. interest expense for the quarter ending 2010-12-31 was $72.34K.
- REGENOCELL THERAPEUTICS, INC. interest expense for fiscal 2011 was $441.22K, a 22.45% increase from fiscal 2010.
- REGENOCELL THERAPEUTICS, INC. interest expense for fiscal 2010 was $360.32K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2011-12-31 | $50.19K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-25 | $256.20K derived: sum of 2 quarters · filed 2012-05-25 | $350.56K derived: sum of 3 quarters · filed 2012-05-25 | $441.22K 10-K · filed 2012-05-25 |
| 2011-09-30 | $206.01K 10-Q · filed 2011-11-21 | $300.37K derived: sum of 2 quarters · filed 2011-11-21 | $391.03K 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $94.36K 10-Q/A · filed 2011-09-01 | $185.02K 10-Q/A · filed 2011-09-01 | ||
| 2010-12-31 | $72.34K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-25 | $79.33K derived: sum of 2 quarters · filed 2012-05-25 | $309.50K derived: sum of 3 quarters · filed 2012-05-25 | $360.32K 10-K · filed 2012-05-25 |
| 2010-09-30 | $6.99K 10-Q · filed 2011-11-21 | $237.16K derived: sum of 2 quarters · filed 2011-11-21 | $287.98K 10-Q · filed 2011-11-21 | |
| 2010-06-30 | $230.16K 10-Q/A · filed 2011-09-01 | $280.99K 10-Q/A · filed 2011-09-01 |